BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27571130)

  • 1. Fluorine-18 fluorodeoxyglucose avid thyroid incidentalomas on PET/CT scan in cancer patients: how sinister are they?
    Hassan A; Riaz S; Zafar W
    Nucl Med Commun; 2016 Oct; 37(10):1069-73. PubMed ID: 27571130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging.
    Chen W; Parsons M; Torigian DA; Zhuang H; Alavi A
    Nucl Med Commun; 2009 Mar; 30(3):240-4. PubMed ID: 19262287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
    Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
    Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation.
    Kim BH; Na MA; Kim IJ; Kim SJ; Kim YK
    Ann Nucl Med; 2010 Dec; 24(10):721-8. PubMed ID: 20830537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
    Brindle R; Mullan D; Yap BK; Gandhi A
    Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
    Pagano L; Samà MT; Morani F; Prodam F; Rudoni M; Boldorini R; Valente G; Marzullo P; Baldelli R; Appetecchia M; Isidoro C; Aimaretti G
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):528-34. PubMed ID: 21575027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental thyroid uptake on F-18 FDG PET/CT: correlation with ultrasonography and pathology.
    Kang BJ; O JH; Baik JH; Jung SL; Park YH; Chung SK
    Ann Nucl Med; 2009 Oct; 23(8):729-37. PubMed ID: 19768518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
    Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
    Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT).
    Familiar C; Merino S; Valhondo R; López C; Pérez X; De Los Monteros PE; Hernández F; Pazos M; Pallarés R; Pascual AC
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation.
    Hagenimana N; Dallaire J; Vallée É; Belzile M
    J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):22. PubMed ID: 28320460
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A
    J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy.
    Wong C; Lin M; Chicco A; Benson R
    Acta Radiol; 2011 Oct; 52(8):899-904. PubMed ID: 21873505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
    Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
    J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
    J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
    Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
    Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas.
    Bertagna F; Treglia G; Piccardo A; Giubbini R
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3866-75. PubMed ID: 22904176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: incidence, malignancy risk, and comparison of standardized uptake values.
    Kao YH; Lim SS; Ong SC; Padhy AK
    Can Assoc Radiol J; 2012 Nov; 63(4):289-93. PubMed ID: 22136969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
    Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Ruhlmann M; Ruhlmann J; Görges R; Herrmann K; Antoch G; Keller HW; Ruhlmann V
    Thyroid; 2017 Oct; 27(10):1300-1306. PubMed ID: 28793848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.